Visura Adds Greg Swanson as Senior Vice President of Sales to Support Commercial Growth
MINNEAPOLIS (April 17, 2023) — Visura Technologies, Inc., a medical device company dedicated to delivering state-of-the-art visualization...
top of page
Let's Be Clear
There's an alternative to blind TEE intubation
Introducing TEECAD
The world's first, FDA-cleared, disposable camera that seamlessly connects to a transesophageal echocardiogram (TEE) probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.
With TEECAD, there is no need to navigate blind
TEE is the gold standard for imaging heart valves and atria, however physicians currently place TEE ultrasound probes blindly resulting in failed intubations that can lead to major complications such as esophageal or pharyngeal perforation.
TEECAD's real-time visualization provides precise and clear images during TEE probe placement. To learn more about the role of imaging in the TEE procedure, download our latest white paper.
Recent News
Milestones
2015
Founded by David Marmor, MD
2018
FDA Clearance - TEECAD
Two US Patents Granted
Series A Closed
TEECAD Gen 2 Development
2020
Design Optimization for Manufacturing and Scalability
Japan Patent Granted
2021
First in-human
TEECAD Gen 2 Northshore Medical, Evanston, IL
2019
Two Additional US Patents Granted
Board of Directors
David Marmor, MD
Founder & CMO
Cardiologist
Focus on non-invasive imaging
Christine Horton
President & CEO
30 years MedTech
Cardiovascular Systems, eV3, CoreSpine Techologies
Kathy Tune
Board Chair & CFO/COO Marani Health
25+ years healthcare and venture investing
Fourth Element Capital, Thomas, McNerney & Partners
Paul Quadros
30+ years healthcare and venture investing
Tenex Greenhouse Ventures, Corautus Genetics, Cardiac Science
Stan Weissbrot
Angel Investor & Board Member
Allstate, Five Star Diamond Holdings
Mike Black
VP / GM Consumbles, Zoll
Former CEO of Advanced Circulatory Systems
bottom of page